“…In Ireland, MRSA is endemic in hospitals, and since 2002, the pvl-negative ST22-MRSA-IV clone has accounted for 70 to 80% of MRSA from bloodstream infections (BSIs) each year (28,29). Between 1999 and 2005, a prevalence rate of 1.8% was reported for pvl-positive MRSA in Ireland, and six distinct pvl-positive MRSA clones (ST30, ST8, ST22, ST80, ST5, and ST154, all harboring SCCmec IV) were identified, some of which were probably imported (30).…”